Skip to main content
Clinical Trials/NCT06477978
NCT06477978CompletedNot Applicable

The Prevalence of Sarcopenia in a Cohort of Patients With End Stage Kidney Disease on Haemodialysis Patients and Its Correlation With Mortality

Kasr El Aini Hospital1 site in 1 country274 target enrollmentStarted: February 15, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
274
Locations
1
Primary Endpoint
One year mortality

Study Overview

Brief Summary

The study aims to explore the correlation between the prevalence of sarcopenia and one year mortality amongst patients on maintenance hemodialysis

Detailed Description

In our study , we aim to explore the correlation between the prevalence of sarcopenia and one year mortality among patients on maintenance hemodialysis The lean muscle mass was measured using bio-impedance analysis (BIA ). The hand-grip test was used to measure the function .

Sarcopenia was defined using European Working Group on Sarcopenia in Older people (EWGSOP) definition which involves reduced muscle function and reduced muscle mass

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with End stage kidney disease on maintenance dialysis

Exclusion Criteria

  • unable to consent or terminal malignancy

Outcomes

Primary Outcomes

One year mortality

Time Frame: One year

All cause mortality of patients with end stage kidney disease on hemodialysis

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Kasr El Aini Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Tarek Samy Abdelaziz

Associate professor of Internal medicine and nephrology

Kasr El Aini Hospital

Study Sites (1)

Loading locations...

Similar Trials